By Iain Gilbert
Date: Tuesday 14 Jul 2026
(Sharecast News) - Analysts at Berenberg maintained their 'buy' rating on Genus on Tuesday as it said the animal genetics firm's latest trading update showed strong momentum across the business, prompting another upgrade to full‑year guidance and extending what the broker described as a sustained run of improvements since early 2025.
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news